Company Search:
Advanced Search
Sponsored Links
Hybrigenics SA Company Snapshot
Hybrigenics SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hybrigenics SA with three other companies in this sector in France: Genfit (2015 sales of 4.36 million Euro [US$4.74 million] of which 100% was Therapeutic Drugs), IntegraGen SA (5.58 million Euro [US$6.08 million] ), and GeNeuro SA (2.54 million Euro [US$2.76 million] ).

Sales Analysis. During the year ended December of 2015, sales at Hybrigenics SA were 4.64 million Euro (US$5.05 million). This is a decrease of 5.0% versus 2014, when the company's sales were 4.88 million Euro. The sales level in 2015 was fairly close to the level five years ago: in 2010, Hybrigenics SA had sales of 4.54 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hybrigenics SA
  Stock Performance Chart for Hybrigenics SA
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): .83
(Figures in Euro)
1 Week -2.4%   13 Weeks -7.8%  
4 Weeks -6.7%   52 Weeks -34.6%  
Hybrigenics SA Key Data:
  Ticker: ALHYG Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 4,641,000
(Year Ending Jan 2016).
Employees: 46
  Currency: Euro Market Cap: 29,710,678
  Fiscal Yr Ends: December Shares Outstanding: 35,795,998
  Share Type: Closely Held Shares: 3,223,940
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.